Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-14

Clinical Trial Update: Effects of Combined Treatment by Botulinum Toxin and Lokomat® on Walking Ability in Chronic Stroke [NA]

View source ↗

Summary

A completed clinical trial assessed whether combining botulinum toxin injections with Lokomat-guided gait therapy improves walking in people with chronic stroke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Stroke | NA | Status: COMPLETED